American Research & Management Co. trimmed its holdings in shares of Safeguard Scientifics, Inc (NYSE:SFE) by 5.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 116,974 shares of the asset manager’s stock after selling 6,942 shares during the quarter. American Research & Management Co.’s holdings in Safeguard Scientifics were worth $1,310,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Granahan Investment Management Inc. MA grew its holdings in Safeguard Scientifics by 20.8% during the third quarter. Granahan Investment Management Inc. MA now owns 646,492 shares of the asset manager’s stock valued at $8,631,000 after purchasing an additional 111,370 shares during the period. Dimensional Fund Advisors LP grew its holdings in Safeguard Scientifics by 6.6% during the second quarter. Dimensional Fund Advisors LP now owns 1,147,008 shares of the asset manager’s stock valued at $13,649,000 after purchasing an additional 71,379 shares during the period. New York State Common Retirement Fund grew its holdings in Safeguard Scientifics by 70.6% during the second quarter. New York State Common Retirement Fund now owns 141,814 shares of the asset manager’s stock valued at $1,688,000 after purchasing an additional 58,689 shares during the period. Bank of Montreal Can grew its holdings in Safeguard Scientifics by 10.7% during the fourth quarter. Bank of Montreal Can now owns 606,520 shares of the asset manager’s stock valued at $6,793,000 after purchasing an additional 58,498 shares during the period. Finally, State Street Corp grew its holdings in Safeguard Scientifics by 7.9% during the second quarter. State Street Corp now owns 383,000 shares of the asset manager’s stock valued at $4,558,000 after purchasing an additional 28,161 shares during the period. 76.25% of the stock is owned by institutional investors.

Safeguard Scientifics, Inc (SFE) opened at $12.50 on Tuesday. Safeguard Scientifics, Inc has a twelve month low of $10.65 and a twelve month high of $14.40. The firm has a market capitalization of $257.20, a price-to-earnings ratio of -2.78 and a beta of 1.36. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.45.

Several equities analysts have weighed in on the company. Zacks Investment Research lowered Safeguard Scientifics from a “buy” rating to a “hold” rating in a report on Tuesday, January 2nd. Keefe, Bruyette & Woods reissued a “mkt perform” rating and set a $13.25 price objective on shares of Safeguard Scientifics in a report on Wednesday, December 6th. Finally, ValuEngine lowered Safeguard Scientifics from a “hold” rating to a “sell” rating in a report on Tuesday, November 14th.

ILLEGAL ACTIVITY WARNING: “Safeguard Scientifics, Inc (SFE) Shares Sold by American Research & Management Co.” was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://theolympiareport.com/2018/02/13/safeguard-scientifics-inc-sfe-shares-sold-by-american-research-management-co.html.

Safeguard Scientifics Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Want to see what other hedge funds are holding SFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Safeguard Scientifics, Inc (NYSE:SFE).

Institutional Ownership by Quarter for Safeguard Scientifics (NYSE:SFE)

Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.